Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Equity: 2017-2025

Historic Return on Equity for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to 0.23%.

  • Collegium Pharmaceutical's Return on Equity fell 16.00% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 16.00%. This contributed to the annual value of 0.20% for FY2024, which is 4.00% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Return on Equity stood at 0.23% for Q3 2025, which was up 48.30% from 0.16% recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Return on Equity peaked at 0.50% during Q2 2021, and registered a low of -0.22% during Q3 2022.
  • Moreover, its 3-year median value for Return on Equity was 0.23% (2025), whereas its average is 0.21%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by 68bps in 2022, then surged by 60bps in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Return on Equity (Quarterly) stood at 0.32% in 2021, then tumbled by 44bps to -0.13% in 2022, then spiked by 38bps to 0.26% in 2023, then climbed by 4bps to 0.30% in 2024, then declined by 16bps to 0.23% in 2025.
  • Its Return on Equity was 0.23% in Q3 2025, compared to 0.16% in Q2 2025 and 0.19% in Q1 2025.